N/A
Manufactured by Rising Pharma Holdings, Inc.
110,211 FDA adverse event reports analyzed
Last updated: 2026-04-14
CHLORHEXIDINE GLUCONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rising Pharma Holdings, Inc.. The most commonly reported adverse reactions for CHLORHEXIDINE GLUCONATE include FATIGUE, PAIN, RASH, JOINT SWELLING, HYPERSENSITIVITY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHLORHEXIDINE GLUCONATE.
Out of 8,676 classified reports for CHLORHEXIDINE GLUCONATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 110,211 FDA FAERS reports that mention CHLORHEXIDINE GLUCONATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FATIGUE, PAIN, RASH, JOINT SWELLING, HYPERSENSITIVITY, FOLLICULITIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Rising Pharma Holdings, Inc. in connection with CHLORHEXIDINE GLUCONATE. Always verify the specific product and NDC with your pharmacist.